Akva Group Asa · OSL:AKVA
Akva Group Asa — Shareholder Meeting (May 2018)
34 slides from Akva Group Asa's shareholder meeting presentation, May 15, 2018
Slide 1: Annual General Meeting
Annual General Meeting AKVA group ASA Bryne, 15th May 2018
Slide 2: 1. Opening of the annual general meeting
1. Opening of the annual general meeting by the Chairman of the Board and registration of shareholders present Technology for sustainable biology
Slide 3: 2. Election of chair of the meeting and co-signer of minutes
2. Election of chair of the meeting and a person to co-sign the minutes along with the meeting chair Technology for sustainable biology
Slide 4: 3. Approval of the notice and the agenda
3. Approval of the notice to the meeting and the agenda Technology for sustainable biology
Slide 5: 4. Ordinary agenda items
4. Ordinary agenda items 4.1. Presentation of business activities by Group chief executive Hallvard Muri Technology for sustainable biology
Slide 6: Presentation of Business Activities
Presentation of Business Activities Annual General Meeting AKVA group ASA Bryne, 15th May 2018 Hallvard Muri
Slide 7: Highlights 2017
Highlights 2017 • AKVA group has in 2017 completed its best financial performance in the Group's history • Revenue in 2017 of MNOK 2,088 – a 30% increase from 2016 • EBITDA in 2017 of MNOK 240 – a 66% increase from 2016 • Net profit in 2017 of MNOK 100 – a 262% increase from 2016 • Dividend of 1.25
Slide 8: Operational leverage and profitable growth
Operational leverage and profitable growth Revenue EBITDA EPS +68% +132% +81% 2 088 240 3,86 1 603 1 425 1 246 135 144 2,13 2,20 103 1,06 2014 2015 2016 2017 2014 2015 2016 2017 2014 2015 2016 2017 Technology for sustainable biology
Slide 9: High activity across all regions
High activity across all regions Order intake Order backlog +101% +174% 2 471 1 381 1 952 998 1 570 1 231 649 504 2014 2015 2016 2017 2014 2015 2016 2017 Technology for sustainable biology
Slide 10: Where do we deliver
Where do we deliver AKVA group’s geographical regions Income distribution Q4 2017 23%(13%) 8%(10%) 69%(77%) Nordic Americas Export Nordic AKVA group EME Agents and Distributors Americas
Slide 11: Solutions
Solutions Cage Based Technology Land Based Technology Software
Slide 12: CAPEX Based Revenue / OPEX Based Revenue
CAPEX Based Revenue OPEX Based Revenue Technology for sustainable biology
Slide 13: Group Strategy
Group Strategy Focused growth and Operational expansion excellence Increased international focus Improvement programs within sourcing, Land based post smolt logistics and manufacturing Expand services and OPEX based Streamline project execution and service business delivery Product portfolio add-ons
Slide 14: Risk management / Submerge and raise the cage / Underwater feeding
1. Atlantis Subsea Farming AS applied for 6 development licenses the 29th of January 2016 2. The Norwegian Directorate of Fisheries have informed the company that the company’s concept has progressed another step further in the process to get awarded development licenses. 3. The Directorate will go
Slide 15: Outlook – AKVA group
Outlook – AKVA group • Continuing positive outlook for most markets • Land Based – focus on post smolt, high quote bank • Execution of improvement programs, manufacturing, sourcing and logistics • Increasing focus outside Nordic Markets • Expanding services and OPEX based business • Product improvem
Slide 16: AKVA group
AKVAcRovur
Slide 17: 4.2 Approval of the 2017 annual accounts
4. Ordinary agenda items contd. 4.2 Approval of the 2017 annual accounts of AKVA group ASA and the Group, and the board's annual report The board proposes that the general meeting passes the following resolution: “The General Meeting resolved to approve the annual accounts for 2017 for AKVA group AS
Slide 18: Group P&L 2017
Group P&L 2017 (Amounts in NOK 1 000) Technology for sustainable biology
Slide 19: Group balance 2017
Group balance 2017 (Amounts in NOK 1 000) Technology for sustainable biology
Slide 20: Group balance 2017
Group balance 2017 (Amounts in NOK 1 000) Technology for sustainable biology
Slide 21: Summary parent company 2017
Summary parent company 2017 (Amounts in NOK 1 000) AKVA group ASA Income statement 01.01. - 31.12. (in NOK 1 000) NET (LOSS)/PROFIT AND COMPREHENSIVE (LOSS)/PROFIT FOR THE YEAR 33 279 26 251 ALLOCATION OF PROFIT FOR THE YEAR Transferred to other equity 33 279 26 251 Dividends paid 21 -32 272 -19 376
Slide 22: 4.3 Determination of Board members' remuneration
4. Ordinary agenda items contd. 4.3 Determination of Board members’ remuneration In accordance with the proposal from the Nomination Committee, the board proposes that the general meeting passes the following resolution remuneration to the Board of Directors shall be: • Chairman of the board: NOK 31
Slide 23: 4.4 Nomination Committee members' remuneration
4. Ordinary agenda items contd. 4.4 Determination of Nomination Committee members’ remuneration In accordance with the proposal from the Nomination Committee, the board proposes that the general meeting passes the following resolution: The Nomination Committee members’ remuneration shall be set at:
Slide 24: 4.5 Approval of auditors' fees
4. Ordinary agenda items contd. 4.5 Approval of auditors’ fees The board proposes that the general meeting passes the following resolution: "The General Meeting approves the auditor's fees of NOK 652.300 for the 2017 accounting year." Technology for sustainable biology
Slide 25: 4.6 Advisory vote on remuneration guidelines for leading employees
4. Ordinary agenda items contd. 4.6 Advisory vote on the board’s guidelines for the remuneration of leading employees The board proposes that the general meeting passes the following resolution: ” The General Meeting endorses item 2 of the board's statement on the determination of salary and other r
Slide 26: 4.7 Share-linked incentive arrangements guidelines
4. Ordinary agenda items contd. 4.7 Approval of the board's guidelines for share-linked incentive arrangements for leading employees The board proposes that the general meeting passes the following resolution: ” The General Meeting approves item 3 of the board's statement on the determination of sal
Slide 27: 4.8 Statement on corporate governance
4. Ordinary agenda items contd. 4.8 Consideration of the board’s statement on corporate governance in accordance with the Norwegian Accounting Act section 3-3 b The board proposes that the general meeting passes the following resolution: "The General Meeting endorses the board's statement on corpora
Slide 28: 4.9 Election of board members
4. Ordinary agenda items contd. 4.9 Election of board members In accordance with the proposal from the Nomination Committee, the board proposes that the general meeting passes the following resolution: The following are elected as members of the board: Ms. Anne Breiby (elected to 2019) Mr. Hans Kris
Slide 29: 4.10 Election of Nomination Committee members
4. Ordinary agenda items contd. 4.10 Election of Nomination Committee members In accordance with the proposal from the Nomination Committee, the board proposes that the general meeting passes the following resolution: The Nomination Committee shall consist of: Mr. Eivind Helland, Chair (elected to 2
Slide 30: 5. Authorization to increase the share capital
5. Authorization to increase the share capital The board proposes that the general meeting passes the following resolution: "The board is authorized to increase the company’s share capital by up to NOK 2,583,430, through subscription of new shares. The authorization does not authorize the board to w
Slide 31: 6. Authorization to purchase own shares
6. Authorization to purchase own shares The board proposes that the general meeting passes the following resolution: "The board is, pursuant to Section 9-2 to 9-4 of the Public Limited Liability Companies Act, authorized to purchase and hold shares in the Company. The shares to be acquired under thi
Slide 32: 7. Authorisation to approve distribution of dividends
7. Authorisation to the Board to approve the distribution of dividends The board proposes that the general meeting passes the following resolution: "The board of directors is authorised pursuant to the Public Limited Liability Companies Act § 8-2(2) to approve the distribution of dividends based on
Slide 33: Technology for sustainable biology
Technology for sustainable biology
Slide 34: AKVA group
AKVAcRovur